GSK reports positive Phase 3 results for linerixibat in PBC itching
GSK (NYSE:GSK) said a Phase 3 study of its drug linerixibat in the treatment of relentless itching in patients with primary ...
Medscape2h
Dupilumab Beneficial When Antihistamines Fall Short for Chronic Spontaneous Urticaria
Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
pharmaphorum4h
GSK drug raises hopes for patients with PBC itch
Interim results from the ongoing GLISTEN trial of linerixibat, GSK's targeted inhibitor of the ileal bile acid transporter ...
GSK drug meets main goal in late-stage study to treat relentless itch
British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...
Pharmabiz11h
Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS
Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS: Paris, France Tuesday, November 19, 2024, 11:00 H ...
'I'm a pharmacist – what to do if you have a common condition NHS no longer covers'
The NHS has cut back on the medications it covers, meaning 36 conditions are now not treated by the health service – here's ...
Nottingham Post3d
Three things you must do if you have common condition that NHS will no longer treat
A pharmacist has shared three things sufferers of a 'very common' condition should do to treat themselves after it was ...
Jason Biggs' wife among rising head lice victims as $1.3B treatment market soars
The Lice Treatment Global Market Report 2024 from ResearchAndMarkets.com reveals that there has been a 'global rise in the ...
Jenny Mollen finds out she has lice — in the middle of a 5-hour flight
Jenny Mollen posted a video on Instagram two weeks ago while in what looks like a first-class seat with a clear plastic bag ...
Taiwan News4d
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more frequently in patients treated with Iqirvo than placebo in the double-blind period ...
manilatimes4d
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...
Hosted on MSN7d
Diabetic Itching: Causes and How It's Treated
Eun Lee, MD Itching (also known as pruritus) is a common symptom of diabetes, a chronic condition characterized by high blood ...